Sunday, January 05, 2025 10:01:22 PM
While I agree with you completely, in some companies I've seen a runup to approval followed by some retrenching, but eventually going substantially higher.
My point is that traders, those who buy, and sell for small gains, may trade successfully on such action. If the tax nightmare of constantly buying and selling is not a bother, enjoy such trading.
Personally I'm not thrilled by being out of a company because I made a small profit, but I know day traders who don't hold shares overnight. Not being in stock until the market opens avoids bad news before the open tanking a stock, but it also avoids big gains that may come from good news before the bell.
I like our odds at getting great news one of these days and I'm willing to hold for years after that happens as I believe it will just be the beginning of many great days.
Gary
My point is that traders, those who buy, and sell for small gains, may trade successfully on such action. If the tax nightmare of constantly buying and selling is not a bother, enjoy such trading.
Personally I'm not thrilled by being out of a company because I made a small profit, but I know day traders who don't hold shares overnight. Not being in stock until the market opens avoids bad news before the open tanking a stock, but it also avoids big gains that may come from good news before the bell.
I like our odds at getting great news one of these days and I'm willing to hold for years after that happens as I believe it will just be the beginning of many great days.
Gary
Bullish
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
